Astellas Skirts $867M Antitrust Suit Over Heart Test Drug

Law360, New York (September 26, 2012, 3:45 PM EDT) -- A federal judge ruled Monday that a Florida hospital didn't have standing to file an $867 million antitrust class action accusing Astellas Pharma Inc. of abusing a patent monopoly to force health care providers to use only an Astellas-brand cardiac testing drug.

U.S. District Judge Virginia M. Hernandez Covington denied class certification to Lakeland Regional Medical Center Inc. on the grounds that the hospital itself never even had a right to bring the lawsuit, which claimed Astellas violated antitrust laws by tying a particular drug to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.